3 commercial payer policies list 96417. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
3 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of 96417 |
|---|---|---|
| Aldesleukin (Proleukin) | Sep 21, 2023 | Covered |
| Panitumumab (Vectibix) | Feb 5, 2024 | Covered |
| Policy | Effective | Status of 96417 |
|---|---|---|
| Pulmonary Function Testing | Not recorded | Covered |